These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


93 related items for PubMed ID: 3408704

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. A circulating inhibitor of leucocyte sodium transport in patients with advanced liver cirrhosis.
    Sewell RB, Poston L, Wilkinson SP, Williams R.
    Clin Sci (Lond); 1984 Jun; 66(6):741-4. PubMed ID: 6723210
    [Abstract] [Full Text] [Related]

  • 43. Frusemide-sensitive sodium and potassium transport by human leucocytes.
    Johnson VE, Hilton PJ.
    Clin Sci (Lond); 1985 Jan; 68(1):89-91. PubMed ID: 3964733
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Ouabain inhibition of the sodium-potassium pump: estimation of ED50 in different types of human leucocytes in vitro.
    Møller B, Vaag A, Johansen T.
    Br J Clin Pharmacol; 1990 Jan; 29(1):93-100. PubMed ID: 2297465
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Thallium and the sodium pump in human red cells.
    Cavieres JD, Ellory JC.
    J Physiol; 1974 Nov; 243(1):243-66. PubMed ID: 4449062
    [Abstract] [Full Text] [Related]

  • 51. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.
    Roden M, Stingl H, Chandramouli V, Schumann WC, Hofer A, Landau BR, Nowotny P, Waldhäusl W, Shulman GI.
    Diabetes; 2000 May; 49(5):701-7. PubMed ID: 10905476
    [Abstract] [Full Text] [Related]

  • 52. The kinetics of ouabain-sensitive ionic transport in the rabbit carotid artery.
    Heidlage JF, Jones AW.
    J Physiol; 1981 Aug; 317():243-62. PubMed ID: 7310733
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Interaction between specific fatty acids, GLP-1 and insulin secretion in humans.
    Beysen C, Karpe F, Fielding BA, Clark A, Levy JC, Frayn KN.
    Diabetologia; 2002 Nov; 45(11):1533-41. PubMed ID: 12436337
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Effect of short-term intralipid infusion on the immune response during low-dose endotoxemia in humans.
    Krogh-Madsen R, Plomgaard P, Akerstrom T, Møller K, Schmitz O, Pedersen BK.
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E371-9. PubMed ID: 18056792
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation.
    Sako Y, Grill VE.
    Endocrinology; 1990 Oct; 127(4):1580-9. PubMed ID: 1698143
    [Abstract] [Full Text] [Related]

  • 60. Insulin secretion and cellular glucose metabolism after prolonged low-grade intralipid infusion in young men.
    Jensen CB, Storgaard H, Holst JJ, Dela F, Madsbad S, Vaag AA.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2775-83. PubMed ID: 12788887
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.